National versus international generalizations from cost-effectiveness analyses.
Alan
A
Lyles
D020533:Angiogenesis Inhibitors / Q000191:economics*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D043169:Endostatins / Q000191:economics*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*
D020533:Angiogenesis Inhibitors; D043169:Endostatins